Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2

by Kathleen I. Pritchard, Howard A. Burris, Yoshinori Ito, Hope S. Rugo, Shaker Dakhil, Gabriel N. Hortobagyi, Mario Campone, Tibor Csöszi, José Baselga, Puttisak Puttawibul, Martine Piccart, Daniel Heng, Shinzaburo Noguchi, Vichien Srimuninnimit, Hugues Bourgeois, Antonio Gonzalez Martin, Karen Osborne, Ashok Panneerselvam, Tetiana Taran, Tarek Sahmoud, Michael Gnant
Published 2018

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2

by Shinzaburo Noguchi, Norikazu Masuda, Hiroji Iwata, Hirofumi Mukai, Jun Horiguchi, Puttisak Puttawibul, Vichien Srimuninnimit, Yutaka Tokuda, Katsumasa Kuroi, Hirotaka Iwase, Hideo Inaji, Shozo Ohsumi, Woo Chul Noh, Takahiro Nakayama, Shinji Ohno, Yoshiaki Rai, Byeong Woo Park, Ashok Panneerselvam, Mona El-Hashimy, Tetiana Taran, Tarek Sahmoud, Yoshinori Ito
Published 2018